6550--Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved CEDIA and DRI Drugs of Abuse Reagents, Calibrators, and Controls for Assays used with Beckman AU480 Analyzers
ID: 36C26324Q1195Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNETWORK CONTRACT OFFICE 23 (36C263)Saint Paul, MN, 55101, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Veterans Affairs intends to award a sole source contract to Microgenics Corporation for the procurement of FDA-approved CEDIA and DRI Drugs of Abuse reagents, calibrators, and controls specifically for use with Beckman AU480 analyzers at the Minneapolis VA Medical Center. This contract is critical as the Minneapolis VA's Toxicology Laboratory serves as the exclusive national provider for Federal Workplace Urine Drugs of Abuse Testing among VA Hospitals, necessitating compliance with HHS SAMHSA certification through the use of specific FDA-approved products. Interested vendors are invited to submit capability statements by September 18, 2024, to demonstrate their ability to meet the requirements, with all submissions directed to Contract Specialist Alisha Milander at Alisha.Milander@va.gov. The contract is set to commence on October 1, 2024, and will include multiple option years to support ongoing operational needs.

    Point(s) of Contact
    Alisha MilanderContract Specialist
    701-239-3700 x3176
    Alisha.Milander@va.gov
    Files
    Title
    Posted
    The Minneapolis VA Medical Center intends to procure FDA-approved CEDIA and DRI Drugs of Abuse reagents, calibrators, and controls solely from Microgenics Corporation for use with Beckman AU480 analyzers. This presolicitation notice serves to inform potential vendors of the Government's intent to award a sole source contract, emphasizing that all responsible parties may submit capability statements for consideration. The Minneapolis VA's Toxicology Laboratory is the exclusive national provider for Federal Workplace Urine Drugs of Abuse Testing among VA Hospitals, necessitating specific FDA-approved products to maintain HHS SAMHSA certification. Despite evaluating alternatives, Microgenics is deemed the sole manufacturer of required items, necessary for compliance and operational efficiency. Current pricing from authorized distributors indicates potential cost inefficiencies, further justifying the exclusive procurement from Microgenics. Responses must be submitted electronically by September 18, 2024, with all interested sources required to validate their capabilities and registration in SAM. This contract spans from October 1, 2024, and includes multiple option years, reinforcing the laboratory's ongoing operational requirements.
    Similar Opportunities
    6640--FY 25 Molecular Random Access Analyzer Notification of Intent to Sole Source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the VA Caribbean Healthcare System through Network Contracting Office 8, intends to negotiate a sole source contract with Cepheid for the provision of Molecular Random Access Analyzers. This procurement is essential for meeting the government's requirement for rapid, simultaneous testing, delivering results in under three hours, which is critical for healthcare support to veterans. The contract will cover a base year of twelve months, with four optional extensions of twelve months each, and is being pursued under FAR part 8.405-6 (1)(B) due to Cepheid's exclusivity as the sole provider in Puerto Rico. Interested parties must submit any responses challenging the sole source by November 14, 2024, at 1:30 PM EST, to Contract Specialist Darrin Alexander at darrin.alexander2@va.gov.
    6550--Brand Name Beckman Coulter Navios Flow Cytometer reagents and supplies
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, intends to procure brand-name Beckman Coulter Navios Flow Cytometer reagents and supplies through a Blanket Purchase Agreement (BPA) for a duration of five years. This procurement is aimed at supporting the Central Arkansas Veterans Healthcare System, with products ordered on an as-needed basis, including various cytometer reagents and controls essential for diagnostic purposes. Interested parties are required to demonstrate their capability to meet the specified requirements, including providing an authorization letter from Beckman Coulter and ensuring timely delivery, with responses due by November 12, 2024, and an anticipated award date of December 1, 2024. For inquiries, interested vendors should contact Contracting Officer Anthony Marion at anthony.marion2@va.gov by November 6, 2024.
    6550--Lexington Ortho Clinical Diag - Blood Bank
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 9, intends to award a sole source contract to Ortho Clinical Diagnostics for the provision of specific reagents and consumables necessary for the ORTHO Vision Swift ID-Micro Typing System at the Lexington VA Medical Center. This procurement is critical as Ortho Clinical Diagnostics is the only manufacturer capable of supplying products that are compatible with the existing equipment, ensuring the effective operation of the blood bank services. Interested vendors are invited to submit capability statements by 10:00 a.m. CT on November 15, 2024, to james.moore20@va.gov; however, this notice does not constitute a competitive solicitation, and the government retains discretion over the procurement process.
    6640--VA Central California Health Care System Chemistry & Immunoassay CPRR Equipment and Tests
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified contractors to provide clinical laboratory analyzer equipment for Chemistry and Immunoassay testing on a Cost Per Reportable Result (CPRR) basis for the VA Central California Health Care System. This procurement involves a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which will span from April 2025 to September 2029, and includes specific ordering periods for various laboratory tests and equipment. The initiative is crucial for enhancing diagnostic capabilities and ensuring high-quality healthcare services for veterans, with a focus on automation, reliability, and compliance with federal regulations. Interested parties can contact Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov or David J. Alvarez at david.alvarez4@va.gov for further details regarding the solicitation, identified as 36C26125Q0065.
    The Navy Medical Readiness Logistics Command Detachment Fort Detrick has a requirement for the Drug Demand Reduction Program, for the initial (screen) immunoassay for the detection of 6-Acetylmorphine Immunoassay Reagent Kits in urine > 10 ng/mL.
    Active
    Dept Of Defense
    The Department of Defense, specifically the Navy Medical Readiness Logistics Command Detachment Fort Detrick, is seeking proposals for the procurement of FDA-approved Immunoassay Reagent Kits designed for the detection of 6-acetylmorphine (6AM) in urine samples. The contract requires vendors to provide reagent kits compatible with Beckman Coulter AU5800 series analyzers, capable of conducting up to 500,000 tests per month over a five-year period, while adhering to stringent FDA and quality management documentation standards. This procurement is critical for the Drug Demand Reduction Program, ensuring accurate and reliable drug testing within the Department of Defense. Interested vendors must submit technical documentation by October 25, 2024, with final quotes due by November 22, 2024. For further inquiries, contact James Berghaier at 215-697-2022 or via email at james.berghaier@navy.mil.
    6550--VISN22 Special Stains Analyzer Procurement
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking suppliers for the procurement of specialized stains analyzers and associated services for the VISN 22 region, which includes facilities such as the VA Phoenix and Tucson Health Systems. This procurement aims to acquire the Artisan Link Pro Special Stains System, along with necessary supplies, consumables, and preventive maintenance for a period of up to five years, ensuring high standards of laboratory analysis and operational efficiency. The opportunity is particularly focused on engaging small businesses, including Service-Disabled Veteran-Owned Small Businesses (SDVOSB) and Veteran-Owned Small Businesses (VOSB), to foster market participation and compliance with federal guidelines. Interested parties must submit their capability statements and detailed company information by November 19, 2024, to the Contract Specialist, Rebecca Gaba, at Rebecca.Gaba@va.gov.
    BPA Master - Reagents for Luminex 3D
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to establish a Blanket Purchase Agreement on a sole source basis with One Lambda, Inc. for the procurement of laboratory reagents essential for the Luminex 3D Instrument System. This procurement is justified under the statutory authority permitting Other than Full and Open Competition, as outlined in FAR 6.302-1, indicating that only One Lambda can meet the agency's specific requirements. The reagents are crucial for immunology testing and transplantation compatibility, supporting the operations of the Immunology Lab Department at Walter Reed National Military Medical Center. Interested parties capable of providing the requested reagents must submit their capabilities and pricing by 10:00 am EST on November 8, 2024, via email to the designated contacts, Ealed Nuru and Erica S. Oh.
    Q517--Omnicell New Preventative Maintenance Service Package
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) Network Contracting Office 19 intends to award a sole source Fixed Price Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to Omnicell, INC. for the provision of preventative maintenance and support for the Omnicell Medication Supply Station and System. This contract will include enhancements such as the addition of new software and capabilities, ensuring the operational efficiency of the medication dispensing systems critical to healthcare services. Interested firms may submit written notifications demonstrating their ability to meet the requirements by November 14, 2024, at 10:00 AM Mountain Standard Time, with all responses directed to Contract Specialist David Glanton at david.glanton@va.gov. Contractors must be registered in the System for Award Management (SAM) to be eligible for consideration, and the estimated period of performance for this contract is from February 1, 2025, to January 31, 2028.
    Q301--Pharmacy Sterile Compounding Services
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for an Accredited Clinical Laboratory to provide pharmacy sterile compounding services at the Durham VA Health Care System and Greenville Health Care Center. The selected laboratory will conduct competency and environmental testing in compliance with USP <797> standards and must hold ISO/IEC 17025 certification, ensuring the safety and efficacy of pharmaceuticals. This contract, numbered 36C24625Q0158, has an estimated total value of $19 million and is open for bids until November 15, 2024, with the contract period beginning on the same date and options for extensions over five years. Interested offerors must demonstrate their qualifications, submit a technical proposal, and be registered in the System for Award Management (SAM) by the submission deadline; inquiries can be directed to Contract Specialist Cherisse A Hall at Cherisse.Hall@va.gov.
    Sources Sought RFI Fecal Immunochemical Test
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting a Sources Sought Request for Information (RFI) to identify vendors capable of providing Fecal Immunochemical Test (FIT) analyzers and assays. The RFI seeks detailed information regarding the analyzers' volume capabilities, accuracy levels, space dimensions, turnaround times for test results, and automation capabilities for reading test results. This initiative is crucial for enhancing diagnostic capabilities within the Veterans Affairs healthcare system. Interested vendors must submit their inquiries by November 11, 2024, and responses by November 18, 2024, via email to the designated government contacts, Harry R Grambo III and Virgil “Butch” Jones.